MedTrace Logo

Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer

NCT07684508 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 154

Last updated 2026-08-05

No results posted yet for this study

Summary

To investigate the safety and efficacy of moderately hypofractionated intensity-modulated radiotherapy in the treatment of postoperative cervical cancer

Conditions

  • Hypofractionated Radiotherapy
  • Intensity-modulated Radiotherapy
  • Cervical Cancers

Interventions

RADIATION

Postoperative Radiotherapy

Postoperative moderately hypofractionated IMRT (2.5Gy per fraction, 17 fractions, once a day)

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER

  • Manni Huang

    lead OTHER

Principal Investigators

  • MAN NI HUANG, MD · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-10
Primary Completion
2030-12-30
Completion
2030-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07684508 on ClinicalTrials.gov